Cargando…
COVID-19 and stock market performance: Evidence from the RCEP countries()
As the world's largest trading bloc, the agreement of RCEP, which was formalized in September 2020, is believed to play a non-neglectable role in the post-pandemic recovery. Real economies and the capital markets of the participating countries will have greater interactions due to tariff reduct...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597539/ http://dx.doi.org/10.1016/j.iref.2022.10.013 |
_version_ | 1784816115371737088 |
---|---|
author | Zhang, Wenwen Cao, Shuo Zhang, Xuan Qu, Xuefeng |
author_facet | Zhang, Wenwen Cao, Shuo Zhang, Xuan Qu, Xuefeng |
author_sort | Zhang, Wenwen |
collection | PubMed |
description | As the world's largest trading bloc, the agreement of RCEP, which was formalized in September 2020, is believed to play a non-neglectable role in the post-pandemic recovery. Real economies and the capital markets of the participating countries will have greater interactions due to tariff reduction and negative lists. By looking into the shocks in early 2020 that affect the stock markets of RCEP participating countries, we measure the stock market reaction to common risks just before the RCEP agreement was formalized. Following return-based, volume-based and liquidity-based event-study approaches, we use daily data from 11 Asia-Pacific countries to examine the stock market reactions. We find that RCEP economies for which the agreement took effect on January 1st, 2022 showed better risk resistance in response to COVID-19 shocks. In the long run, trading benefits brought by the RCEP agreement are expected to form and strengthen a system of circular flow of international trading activities among the participating countries, which will in turn increase the risk resistance ability of their stock markets. |
format | Online Article Text |
id | pubmed-9597539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95975392022-10-26 COVID-19 and stock market performance: Evidence from the RCEP countries() Zhang, Wenwen Cao, Shuo Zhang, Xuan Qu, Xuefeng International Review of Economics & Finance Article As the world's largest trading bloc, the agreement of RCEP, which was formalized in September 2020, is believed to play a non-neglectable role in the post-pandemic recovery. Real economies and the capital markets of the participating countries will have greater interactions due to tariff reduction and negative lists. By looking into the shocks in early 2020 that affect the stock markets of RCEP participating countries, we measure the stock market reaction to common risks just before the RCEP agreement was formalized. Following return-based, volume-based and liquidity-based event-study approaches, we use daily data from 11 Asia-Pacific countries to examine the stock market reactions. We find that RCEP economies for which the agreement took effect on January 1st, 2022 showed better risk resistance in response to COVID-19 shocks. In the long run, trading benefits brought by the RCEP agreement are expected to form and strengthen a system of circular flow of international trading activities among the participating countries, which will in turn increase the risk resistance ability of their stock markets. Elsevier Inc. 2023-01 2022-10-25 /pmc/articles/PMC9597539/ http://dx.doi.org/10.1016/j.iref.2022.10.013 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Zhang, Wenwen Cao, Shuo Zhang, Xuan Qu, Xuefeng COVID-19 and stock market performance: Evidence from the RCEP countries() |
title | COVID-19 and stock market performance: Evidence from the RCEP countries() |
title_full | COVID-19 and stock market performance: Evidence from the RCEP countries() |
title_fullStr | COVID-19 and stock market performance: Evidence from the RCEP countries() |
title_full_unstemmed | COVID-19 and stock market performance: Evidence from the RCEP countries() |
title_short | COVID-19 and stock market performance: Evidence from the RCEP countries() |
title_sort | covid-19 and stock market performance: evidence from the rcep countries() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597539/ http://dx.doi.org/10.1016/j.iref.2022.10.013 |
work_keys_str_mv | AT zhangwenwen covid19andstockmarketperformanceevidencefromthercepcountries AT caoshuo covid19andstockmarketperformanceevidencefromthercepcountries AT zhangxuan covid19andstockmarketperformanceevidencefromthercepcountries AT quxuefeng covid19andstockmarketperformanceevidencefromthercepcountries |